Key result
Various drugs are associated with QTc prolongation and pose a significant clinical concern.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to QTc risks across agents; leaves open prospective validation of specific drugs and thresholds.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2001) studied this question. Various drugs are associated with QTc prolongation, representing a significant clinical and pharmacological concern.
Synapse has enriched 10 related papers. Consider them for comparative context: